Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NVST
NVST logo

NVST Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Envista Holdings Corp (NVST) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
27.880
1 Day change
0.14%
52 Week Range
30.420
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Envista Holdings Corp (NVST) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock shows positive financial growth, favorable analyst sentiment, and a stable technical setup, making it a solid choice for a long-term portfolio.

Technical Analysis

The technical indicators suggest a bullish trend. The MACD histogram is positive at 0.217, the RSI is neutral at 60.245, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above the key pivot level of 26.326, with resistance levels at 27.384 and 28.038, indicating potential upward movement.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate bullish sentiment in the options market. Implied volatility is high at 54.12, with an IV percentile of 84.8, suggesting strong interest in the stock.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
9

Positive Catalysts

  • Strong Q4 2025 financial performance with revenue up 14.96% YoY and net income up 2641.67% YoY.

  • Analysts have set an average price target of $28.50, indicating potential upside.

  • Multiple analysts have upgraded the stock to Outperform, citing strong growth and execution.

  • Recent overweight rating and positive news sentiment may attract institutional interest.

Neutral/Negative Catalysts

  • Citi's neutral rating and cautious view on the dental sector due to macroeconomic pressures.

  • Gross margin dropped by 3.74% YoY, which may indicate cost pressures.

Financial Performance

Envista Holdings demonstrated strong financial performance in Q4 2025. Revenue increased by 14.96% YoY to $750.6M, net income surged by 2641.67% YoY to $32.9M, and EPS grew by 1900% YoY to $0.2. However, gross margin declined by 3.74% YoY to 55.04%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are generally optimistic about NVST, with several upgrades to Outperform and price target increases. The average price target is $28.50, suggesting potential upside from the current price of $26.94. However, Citi remains neutral on the stock due to macroeconomic concerns in the dental sector.

Wall Street analysts forecast NVST stock price to fall
13 Analyst Rating
Wall Street analysts forecast NVST stock price to fall
5 Buy
7 Hold
1 Sell
Moderate Buy
Current: 27.840
sliders
Low
18
Averages
22.22
High
27
Current: 27.840
sliders
Low
18
Averages
22.22
High
27
Citi
Daniel Grosslight
Neutral
initiated
$29
AI Analysis
2026-04-15
New
Reason
Citi
Daniel Grosslight
Price Target
$29
AI Analysis
2026-04-15
New
initiated
Neutral
Reason
Citi analyst Daniel Grosslight initiated coverage of Envista with a Neutral rating and $29 price target. The firm launched the animal health and dental sectors with a "cautiously optimistic" view. Citi favors the animal health group, saying the the "humanization" pet trend is real and should drive more spending. The firm's top pick is Zoetis. It sees the weak macro backdrop pressuring the dental sector. Citi expects a trade-down to lower cost implants and orthodontics. Citi's top dental pick is Henry Schein.
Evercore ISI
Outperform
to
Outperform
downgrade
$32 -> $30
2026-04-08
Reason
Evercore ISI
Price Target
$32 -> $30
2026-04-08
downgrade
Outperform
to
Outperform
Reason
Evercore ISI lowered the firm's price target on Envista to $30 from $32 and keeps an Outperform rating on the shares. The firm made several price target adjustments and additions to the firm's Tactical call lists as part of the firm's healthcare technology and distribution preview for Q1.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NVST
Unlock Now

People Also Watch